NCT04064034View on ClinicalTrials.gov

ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Pancreas CancerPancreas Cyst
Interventions
OTHER

Lateral Flow Assay (LFA)

Test to detect the Quiescin Sulfhydryl Oxidase 1 (QSOX1) protein

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04064034 - ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer | Biotech Hunter | Biotech Hunter